915237-02-4Relevant academic research and scientific papers
IAP BIR domain binding compounds
-
Page/Page column 51; 52, (2016/04/05)
A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.
IAP BIR DOMAIN BINDING COMPOUNDS
-
Page/Page column 81; 88; 89, (2008/06/13)
The present invention discloses an isomer, enantiomer, diastereoisomer, tautomer, prodrug, pharmaceutically acceptable salt of a compound of formula I and pharmaceutical compositions thereof useful in modulating IAP function via preventing binding of a BI
